Development and Histopathological Characterization of Tumorgraft Models of Pancreatic Ductal Adenocarcinoma

Pancreatic cancer is the one of the deadliest of all malignancies. The five year survival rate for patients with this disease is 3-5%. Thus, there is a compelling need for novel therapeutic strategies to improve the clinical outcome for patients with pancreatic cancer.  Several groups have demonstra...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Patrick L., Council, Leona N., Christein, John D., Arnoletti, J. Pablo, Heslin, Marty J., Gamblin, Tracy L., Richardson, Joseph H., Bjornsti, Mary-Ann, Yoon, Karina J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806809/
https://www.ncbi.nlm.nih.gov/pubmed/24194913
http://dx.doi.org/10.1371/journal.pone.0078183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3806809/
https://www.ncbi.nlm.nih.gov/pubmed/24194913
http://dx.doi.org/10.1371/journal.pone.0078183

Ejemplares similares